Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
221.61
-3.14 (-1.40%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
927,644
Open
225.29
Bid (Size)
208.21 (1)
Ask (Size)
228.72 (1)
Prev. Close
224.75
Today's Range
220.37 - 225.29
52wk Range
161.65 - 275.00
Shares Outstanding
50,396,622
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Analyst Landscape: 7 Takes On Charles River
May 10, 2024
Via
Benzinga
CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-5.40%
-5.40%
1 Month
-3.69%
-3.69%
3 Month
-9.53%
-9.53%
6 Month
+17.23%
+17.23%
1 Year
+11.22%
+11.22%
More News
Read More
Charles River Laboratories Announces First-Quarter 2024 Results
May 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The 7 Best Growth Stocks to Buy in May 2024
May 08, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 07, 2024
Via
Benzinga
Evaluating Charles River: Insights From 7 Financial Analysts
March 18, 2024
Via
Benzinga
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
May 02, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
April 22, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
April 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
April 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
April 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
April 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Production for Ship of Theseus
April 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
April 01, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
March 27, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
March 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
March 14, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Top 3 Healthcare Stocks to Buy in March 2024
March 07, 2024
Via
InvestorPlace
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
March 07, 2024
Via
InvestorPlace
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
March 06, 2024
Via
Investor's Business Daily
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
February 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
February 20, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.